AI applications in life sciences: Use cases for pharma, biotech and medtech

Welcome to AI Transformation 101, where we cover the latest industry trends and showcase best practices for your organization to turn bold, innovative ideas into action. This blog explores everything you need to know about AI’s impact on life sciences, including key trends and applications.

AI is reshaping life sciences, unlocking possibilities for accelerated innovation and improved patient outcomes. From drug discovery to predictive analytics, AI is driving unprecedented efficiencies across business functions. But while the potential is vast, leveraging AI effectively requires strategic foresight, robust infrastructure, and a clear understanding of its applications.

For leaders in life sciences, the critical question is not “Should we integrate AI?” but rather, “How do we maximize its impact on our operations and deliver tangible value?” This blog explores the trends, applications, and strategies that can help you answer that question.

How AI is used in life sciences

AI has shifted from being a futuristic concept to a practical, indispensable tool for life sciences companies. At its core, AI allows organizations to process massive volumes of data-something the industry relies on to drive breakthroughs. AI-powered solutions are applied to complex challenges, such as diagnosing diseases earlier, improving clinical trial success rates, and optimizing supply chains.

Key to its value is AI’s ability to learn and improve over time. Unlike traditional technology systems, machine learning algorithms evolve, making them adept at predicting patterns and offering actionable insights tailored to specific use cases.

Why data readiness matters

The lifeblood of any AI application is data. AI relies on well-curated, high-quality, and secure data to function effectively. For life sciences leaders wanting to explore applications in areas like medical imaging or predictive diagnostics, a question to consider is: Is your data ecosystem ready for AI?

Companies that succeed in this space develop robust data governance strategies that ensure security, privacy, and accuracy while complying with evolving regulations. This foundation positions them to harness the full power of AI.

The lifeblood of any AI application is data. AI relies on well-curated, high-quality, and secure data to function effectively.

Key benefits and applications of AI in Life Sciences

AI has carved its way into various business functions within life sciences. Here are some of the most promising use cases transforming the sector.

1. Faster drug discovery

Drug discovery and development traditionally takes 10-15 years and costs billions of dollars.AI is helping companies like Pfizer and Novartis reduce this timeline by analyzing immense datasets, identifying promising compounds, and predicting success rates early in the process.

For instance, generative AI platforms can simulate molecular behavior, drastically improving the efficiency of early-stage research. These platforms enable scientists to explore thousands of compound variations within days rather than months.

2. Predictive analytics for improved patient outcomes

Predictive analytics leverages AI to anticipate trends and outcomes in patient care, drug interactions, and disease progression. For example, health organizations use AI-driven models to predict patient responses to treatment, enabling more personalized medicine.

Accenture cites predictive analytics as one of the leading ways life sciences companies are better managing chronic diseases and enhancing patient care while improving operational efficiency.

3. AI-driven clinical trials

Historically, clinical trials have suffered from inefficiencies, ranging from participant recruitment challenges to high dropout rates. AI helps mitigate these barriers by identifying suitable participants, monitoring adherence to trial protocols, and analyzing real-time results to adjust strategies as needed.

Companies like Deep6 AI are redefining clinical trials by extracting patient data from electronic health records and matching individuals to trials in minutes.

4. Medical imaging and disease diagnosis

AI has revolutionized medical imaging. With tools like PathAI and Zebra Medical Vision, AI can now analyze radiology images faster and more accurately than many human experts. These tools assist doctors in spotting early signs of life-threatening conditions like cancer, enabling earlier treatment and better outcomes.

Challenges life science companies face in AI adoption

While the potential of AI is undeniable, it’s not without challenges. Effectively implementing AI solutions in life sciences requires addressing several complexities.

1. Data privacy and security

Navigating patient data comes with stringent compliance requirements. Companies must prioritize secure AI development practices to adhere to regulations like HIPAA and GDPR. Failure to do so could compromise sensitive patient information.

2. Algorithm bias and ethical considerations

AI models are only as unbiased as the data on which they are trained. Ensuring AI remains equitable and inclusive requires vigilant, ongoing monitoring. Ethical challenges-like obtaining informed consent-need tailored strategies for compliance, particularly in sensitive healthcare environments.

3. Lack of infrastructure and expertise

Creating a data ecosystem ready for AI adoption requires advanced infrastructure, skilled teams, and a forward-looking strategy. Too often, businesses focus on flashy AI applications without the foundational infrastructure to fully support or scale initiatives.

Creating a data ecosystem ready for AI adoption requires advanced infrastructure, skilled teams, and a forward-looking strategy. Too often, businesses focus on flashy AI applications without the foundational infrastructure to fully support or scale initiatives.

Future trends in life sciences AI

Looking ahead, three key trends will shape the role of AI in the life sciences sector.

1. The rise of generative AI

Generative AI is no longer just a tool for marketing and creative fields. It’s a game-changer for life sciences. From creating novel protein structures to simulated clinical environments, generative AI brings endless possibilities to research and development.

2. Intelligent app development

AI’s ability to design intelligent life sciences apps, such as wearable devices capable of advanced diagnostics, redefines the boundaries of healthcare. These tools empower providers with real-time insights that can improve patient outcomes while optimizing costs.

3. Supply chain optimization

Beyond isolated applications, AI will increasingly drive collaboration across life sciences value chains, enhancing data sharing between healthcare providers, researchers, and pharmaceutical companies. This integrated approach will deliver smarter, faster, and more connected health solutions.

Strategic adoption of AI in life sciences

To successfully harness the power of AI, life sciences companies must adopt a strategic approach that aligns technology with their organizational goals while addressing the unique regulatory and ethical challenges of the industry.

A critical first step is conducting a thorough assessment of internal processes to pinpoint areas where AI can drive the most meaningful impact, such as:

• drug discovery
• patient care
• medical imaging
• disease diagnosis
• supply chain optimization

Partnering with AI experts and leveraging tailored solutions will ensure that implementations are purpose-built for industry-specific needs.

Equally important is adherence to the strict regulatory frameworks that govern the life sciences sector. Companies must prioritize data privacy and security, maintaining compliance with standards such as GDPR or HIPAA, depending on their market. This includes ensuring AI systems are transparent and auditable, allowing stakeholders to understand the decision-making logic behind AI-driven recommendations.

On the ethical front, life sciences organizations must foster trust by integrating AI solutions that respect patient data, eliminate bias, and promote fairness. Building cross-functional teams that include ethicists, compliance experts, and technologists will help achieve responsible AI implementations.

Ultimately, a thoughtful, goal-aligned adoption strategy enables life sciences companies to unlock AI’s full potential while navigating regulatory and ethical complexities with confidence.

In the video below, Abid Rahman, Senior Vice President, Innovation at EVERSANA, spoke about how AI transforms life sciences in a recent webinar with Modus Create and IDC:

Where will you start your AI journey?

AI presents life sciences companies with a unique opportunity to revolutionize how they operate-and the stakes couldn’t be higher. By investing in the right areas of AI, companies can streamline processes, improve data-driven decision-making, and ultimately create a competitive edge in today’s complex market.

Explore our life sciences digital transformation practice to see how Modus Create helps pharma, biotech, CRO, and MedTech teams put AI into production.